Why is BrainsWay the only TMS device FDA-cleared to Treat Depression Among Patients 68-86 Years Old?

Watch our recorded webinar on-demand!

Webinar Topics

  • Indication expansion for Major Depressive Disorder
  • How the H1 Coil design is uniquely suited to aging brains 
  • Clinical data (prospective and post-marketing) supporting late-life MDD treatment

Watch the Webinar

Featured Presenters

Colleen Hanlon, PhD

Vice President of Medical Affairs


Dr. Hanlon brings to BrainsWay 17 years of clinical research experience in TMS and brain imaging. She led multidisciplinary clinical research programs at the Medical University of South Carolina and Wake Forest School of Medicine, published over 80 articles, authored six book chapters, and delivered over 100 invited talks and educational sessions globally. Dr. Hanlon received a B.S. from the University of Florida in 2001 and a Ph.D. in Neurobiology from Duke University in 2005.